NMR study of the sites of human hemoglobin acetylated by aspirin

Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology

Volumn 1432, Issue 2, 1999, Pages 333-349

  Xu, Arron S L ^a   Macdonald, Jeffrey M ^a   Labotka, Richard J ^b   London, Robert E ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Aspirin; Hemoglobin; Nuclear magnetic resonance; Protein acetylation

Indexed keywords

ACETYLSALICYLIC ACID; HEMOGLOBIN;

ACETYLATION; ARTICLE; CHEMICAL MODIFICATION; HUMAN; KINETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN AFFINITY; PRIORITY JOURNAL; PROTEIN MODIFICATION; SICKLE CELL ANEMIA;

2,3-DIPHOSPHOGLYCERATE; ASPIRIN; BINDING SITES; CARBON ISOTOPES; HEMOGLOBINS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METHEMOGLOBIN; MUTATION; PHYTIC ACID; SPIN LABELS;

EID: 0033043194     PISSN: 01674838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4838(99)00094-1     Document Type: Article

References (40)

1. Walder J.A., Zaugg R.H., Walder R.Y., Steele J.M., Klotz I.M. Diaspirins that cross-link β chains of hemoglobin: bis(3,5-dibromosalicyl) succinate and bis(3,5-dibromosalicyl) fumarate. Biochemistry. 18:1979;4265-4270.
2. Zaugg R.H., Walder J.A., Walder R.Y., Steele J.M., Klotz I.M. Modification of hemoglobin with analogs of aspirin. J. Biol. Chem. 255:1980;2816-2822.
3. Chatterjee R., Welty E.V., Walder R.Y., Pruitt S.L., Rogers P.L., Arnone A., Walder J.A. Isolation and characterization of a new hemoglobin derivative cross-linked between the α chains (lysine 99α1-lysine 99α2). J. Biol. Chem. 261:1986;9929-9937.
4. Jones R.T., Shih D.T., Fujita T.S., Song Y., Xiao H., Head C., Kluger R. A doubly cross-linked human hemoglobin, effects of cross-links between different subunits. J. Biol. Chem. 271:1996;675-680.
5. E. Beulter, The sickle cell diseases and related disorders, in: W.J. Williams, E. Beulter, A.J. Erslev, M.A. Lichtman (Eds.), Hemoglobins, McGraw-Hill, New York, 1983, pp. 583-609.
6. Ueno H., Manning J.M. Methyl acetyl phosphate, a new type of antisickling agent: site-specific acetylatin agent toward the 2,3-DPG binding site in hemoglobin S. Am. J. Pediatr. Hematol. Oncol. 10:1988;348-350.
7. Riordan J.F., Wacker W.E.C., Vallee B.L. N-Acetylimidazole: a reagent for determination of 'free' tyrosyl residues in proteins. Biochemistry. 4:1965;1758-1765.
8. Moore G.J. Kinetics of acetylation-deacetylation of angiotensin II. Int. J. Peptide Protein Res. 26:1985;469-481.
9. Shamsuddin M., Mason R.G., Ritchey J.M., Honig G.R., Klotz I.M. Sites of acetylation of sickle cell hemoglobin by aspirin. Proc. Natl. Acad. Sci. USA. 71:1974;4693-4697.
10. Klotz I.M., Tam J.W.O. Acetylation of sickle cell hemoglobin by aspirin. Proc. Natl. Acad. Sci. USA. 70:1973;1313-1315.
11. Bridges K.R., Schmidt G.J., Jensen M., Gerami A., Bunn H.F. The acetylation of hemoglobin by aspirin in vitro and in vivo. J. Clin. Invest. 56:1975;201-207.
12. Kluger R., Tsui W.-C. Reaction of the anionic acetylation agent methyl acetyl phosphate with D-3-hydroxybutyrate dehydrogenase. Biochem. Cell Biol. 64:1986;434-440.
13. 13C]aspirin. Biochem. Pharmacol. 57:1999;1233-1244.
14. Labotka R.J., Schwab C.M. A dialysis cell for nuclear magnetic resonance spectroscopic measurement of protein-small molecule binding. Anal. Biochem. 191:1990;376-383.
15. 13C NMR spectroscopy. Org. Magn. Reson. 15:1981;158-161.
16. 12 through the use of new two-dimensional NMR experiments. J. Am. Chem. Soc. 108:1986;4285-4294.
17. States D.J., Haberkorn R.A., Ruben D.J. A two-dimensional nuclear Overhauser experiment with pure absorption phase in four quadrants. J. Magn. Reson. 48:1982;286-292.
18. 15N HSQC experiments optimized to retain full sensitivity. J. Magn. Reson. A. 102:1993;241-245.
19. DeSatz V.B., Santome J.A. Acetylation of bovine growth hormone by N-acetylimidazole. Int. J. Peptide Protein Res. 18:1981;492-499.
20. Kaliman P., Ermacora M.R., Nowicki C., Wolfenstein-Todel C., Santome J.A. Chemical modification of human growth hormone with N-acetylimidazole. Int. J. Peptide Protein Res. 38:1991;38-46.
21. Kinnunen P.M., De Michele A., Lange L.G. Chemical modification of acetyl-CoA:cholesterol O-acyltransferase. 1. Identification of acyl-CoA:cholesterol O-acyltransferase subtypes by differential diethylpyrocarbonate sensitivity. Biochemistry. 27:1988;7344-7350.
22. Brygier J., De Bruin S.H., Van Hoof P.M.K.B., Rollema H.S. The interaction of organic phosphates with human and chicken hemoglobin. Eur. J. Biochem. 60:1975;379-383.
23. Huestis W.H., Raftery M.A. A study of cooperative interactions in hemoglobin using fluorine nuclear magnetic resonance. Biochemistry. 11:1972;1648-1654.
24. Garel M.C., Beuzard Y., Thillet J., Domenget G., Martin J., Galacteros F., Rosa J. Binding of 21 thiol reagents to human hemoglobin in solution and in intact cells. Eur. J. Biochem. 123:1982;513-519.
25. Fowler S.A., Andracki M., Hurst G., Honkan V.A., Walder J., Casteel D.A. Prolongation of the intravascular retention of hemoglobin modified with a long-chain fatty acid derivative. Artif. Cells Blood Substit. Immobil. Biotechnol. 22:1994;27-42.
26. Gerig J.T., Klinkenborg J.C., Nieman R.A. Assignment of fluorine nuclear magnetic resonance signals from rabbit cyanomethemoglobin. Biochemistry. 22:1983;2076-2087.
27. Manoharn P.T., Wang J.T., Alston K., Rifkind J.M. Spin label probes for the environment of cysteine β-93 in hemoglobin. Hemoglobin. 14:1990;41-67.
28. Silva M.M., Rogers P.H., Arnone A. A third quaternary structure of human heoglobin A at 1.7-Å resolution. J. Biol. Chem. 267:1992;17248-17256.
29. a values of the lysine residues in calmodulin. J. Biol. Chem. 268:1993;22420-22428.
30. 13C NMR. J. Biol. Chem. 269:1994;5099-5105.
31. 9K. J. Protein Chem. 13:1994;527-535.
32. Militello V., Cupane A., Leone M., Brinigar W.S., Lu A.-L., Fronticelli C. Dynamic properties of some β-chain mutant hemoglobins. Proteins Struct. Funct. Genet. 22:1995;12-19.
33. Garner M.H., Bogardt R.A. Jr., Gurd F.R.N. Determination of the pK values for the alpha-amino groups of human hemoglobin. J. Biol. Chem. 240:1975;4398-4404.
34. Nigen A.M., Bass B.D., Manning J.M. Reactivity of cyanate with valine-1 (α) of hemoglobin. J. Biol. Chem. 251:1976;7636-7643.
35. Jensen M., Nathan D.G., Bunn H.F. The reaction of cyanate with the α and β subunits in hemoglobin, effects of oxygenation, phosphates and carbon dioxide. J. Biol. Chem. 248:1973;8057-8063.
36. Emerson S.D., La Mar G.N. NMR determination of the orientation of the magnetic susceptibility tensor in cyanomethmyoglobin: a new probe of steric tilt of bound ligand. Biochemistry. 29:1990;1556-1566.
37. Hori H. Analysis of the principal g-tensors in single crystals of ferrimyoglobin complexes. Biochim. Biophys. Acta. 251:1971;227-235.
38. Ueno H., Pospischil M.A., Kluger R., Manning J.M. Methyl acetyl phosphate: a novel acetyllating agent. Its site-specific modification of human hemoglobin A. J. Chromatogr. 359:1986;193-201.
39. Ueno H., Pospischil M.A., Manning J.M., Kluger R. Site-specific modification of hemoglobin by methyl acetyl phosphate. Arch. Biochem. Biophys. 244:1986;795-800.
40. Manning J.M. Preparation of hemoglobin derivatives selectivlely or randomly modified at amino groups. Methods Enzymol. 231:1994;225-246.